Skip to main content

Table 2 chemotherapy combined with trastuzumab

From: Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population

 

Patients (N = 299)

Taxane

146(48.8%)

Vinorelbine

33(11%)

Gemcitabine

75(25.1%)

Cisplatin

60(20.1%)

Pemetrexed

8(2.7%)

Carboplatin

6(2%)

Capecitabine

71(23.7%)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us